Cargando…
Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting
Rapidly expanding systemic treatment options, combined with improved screening, diagnostic, surgical, and radiotherapy techniques, have led to improved survival outcomes for many cancers over time. However, these overall survival gains have disproportionately benefited patients in high-income countr...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645408/ https://www.ncbi.nlm.nih.gov/pubmed/37944089 http://dx.doi.org/10.1200/GO.23.00294 |